A ten-gene tyrosine-metabolism signature defines prognosis and reveals metabo-immune suppression in low-grade astrocytoma

BACKGROUND: Emerging evidence implicates dysregulated tyrosine metabolism in glioma malignancy; however, its cell-type specificity and clinical relevance in low-grade astrocytoma (LGA) remain undefined. METHODS: We integrated single-cell transcriptomes from two independent LGA cohorts (GSE182109 and GSE222850) and mapped tyrosine-metabolic activity across the tumor microenvironment using GSVA. Weighted gene co-expression network analysis (WGCNA) of bulk RNA-seq data was performed to identify a tyrosine metabolism-associated gene module, from which hub genes were extracted. A total of 101 machine learning algorithm combinations were systematically evaluated to construct a prognostic signature, which was subsequently validated in the REMBRANDT and CGGA LGA cohorts. Multidimensional functional analyses, immune deconvolution, CellChat-based intercellular communication analysis, and in vitro functional assays were employed to characterize the underlying biological programs and therapeutic implications. RESULTS: At single-cell resolution, tyrosine metabolism activity was preferentially enriched in astrocytes and exhibited dynamic variation along pseudotime trajectories. WGCNA identified a turquoise module (r = 0.61, p = 4 × 10-16), from which 12 hub genes were identified by univariate Cox regression. A Lasso + CoxBoost-based 10-gene tyrosine metabolism risk model was constructed through systematic evaluation of 101 algorithm combinations. High risk scores independently predicted unfavorable 5-year overall survival (AUC = 0.80 in REMBRANDT; AUC = 0.73 in CGGA). High-risk tumors exhibited activation of interferon-γ response, epithelial-mesenchymal transition (EMT), E2F targets, and G2M checkpoint pathways. Immune profiling revealed significantly elevated infiltration of M2 macrophages and activated mast cells in the high-risk group. CellChat analysis demonstrated that high-risk astrocytes engage in intercellular communication via MIF, PTN, and SPP1 signaling pathways. Functional validation in MOG-G-UVW cells confirmed that RAB3C knockdown significantly promoted migration, invasion, and proliferation (p < 0.0001). CONCLUSIONS: We present a single-cell-resolved, clinically validated tyrosine metabolism-based prognostic signature for LGA. This risk model enables quantitative patient stratification, reveals a metabolically reprogrammed and immune-suppressive tumor microenvironment, and identifies RAB3C as a tumor-suppressive modulator, thereby offering new avenues for the precision management of low-grade astrocytoma.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-16
DOI
https://doi.org/10.1371/journal.pone.0359523
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A ten-gene tyrosine-metabolism signature defines prognosis and reveals metabo-immune suppression in low-grade astrocytoma

Chengde Wang, Yuejun Fan, Yunxiang Chen, Chunwang Wu et al.
3 links
PLoS ONE
Glioma Diagnosis and Treatment
article

A ten-gene tyrosine-metabolism signature defines prognosis and reveals metabo-immune suppression in low-grade astrocytoma

Chengde Wang, Yuejun Fan, Yunxiang Chen, Chunwang Wu, Xiaofeng Lin, Xujian Shun, Huawei Liu, Kaijie Yu
article en

Abstract

BACKGROUND: Emerging evidence implicates dysregulated tyrosine metabolism in glioma malignancy; however, its cell-type specificity and clinical relevance in low-grade astrocytoma (LGA) remain undefined. METHODS: We integrated single-cell transcriptomes from two independent LGA cohorts (GSE182109 and GSE222850) and mapped tyrosine-metabolic activity across the tumor microenvironment using GSVA. Weighted gene co-expression network analysis (WGCNA) of bulk RNA-seq data was performed to identify a tyrosine metabolism-associated gene module, from which hub genes were extracted. A total of 101 machine learning algorithm combinations were systematically evaluated to construct a prognostic signature, which was subsequently validated in the REMBRANDT and CGGA LGA cohorts. Multidimensional functional analyses, immune deconvolution, CellChat-based intercellular communication analysis, and in vitro functional assays were employed to characterize the underlying biological programs and therapeutic implications. RESULTS: At single-cell resolution, tyrosine metabolism activity was preferentially enriched in astrocytes and exhibited dynamic variation along pseudotime trajectories. WGCNA identified a turquoise module (r = 0.61, p = 4 × 10-16), from which 12 hub genes were identified by univariate Cox regression. A Lasso + CoxBoost-based 10-gene tyrosine metabolism risk model was constructed through systematic evaluation of 101 algorithm combinations. High risk scores independently predicted unfavorable 5-year overall survival (AUC = 0.80 in REMBRANDT; AUC = 0.73 in CGGA). High-risk tumors exhibited activation of interferon-γ response, epithelial-mesenchymal transition (EMT), E2F targets, and G2M checkpoint pathways. Immune profiling revealed significantly elevated infiltration of M2 macrophages and activated mast cells in the high-risk group. CellChat analysis demonstrated that high-risk astrocytes engage in intercellular communication via MIF, PTN, and SPP1 signaling pathways. Functional validation in MOG-G-UVW cells confirmed that RAB3C knockdown significantly promoted migration, invasion, and proliferation (p < 0.0001). CONCLUSIONS: We present a single-cell-resolved, clinically validated tyrosine metabolism-based prognostic signature for LGA. This risk model enables quantitative patient stratification, reveals a metabolically reprogrammed and immune-suppressive tumor microenvironment, and identifies RAB3C as a tumor-suppressive modulator, thereby offering new avenues for the precision management of low-grade astrocytoma.

PLoS ONEVol. 21(11)
Wenzhou Medical University (CN), Zhejiang University (CN)
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon